Zhao Yi-Fan, Huang Cheng-Yang, Zhang Zhi-Xin, Liu Run-Ben, Liu Jia-Ling, Li Xiao-Zheng, Guo Guang-Ling, Zhang Chao
Center for Evidence-Based Medicine and Clinical Research, Hubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Hubei, Shiyan, 442000, China.
Center of Women's Health Sciences, Taihe Hospital, Hubei University of Medicine, Hubei, Shiyan, 420000, China.
BMC Psychiatry. 2025 Jul 15;25(1):699. doi: 10.1186/s12888-025-07157-9.
BACKGROUND: Post-traumatic stress disorder (PTSD) is strongly associated with sleep disorders, and current clinical guidelines for PTSD differ in recommending treatment for patients with PTSD associated with sleep disorders. This meta-analysis evaluates the acceptability and efficacy of psychotherapy, pharmacotherapy, and other complementary/alternative therapies, to help clinicians make decisions about treatment regimens for individuals with PTSD and sleep disorders. METHOD: We systematically searched PubMed, EMBASE, the Cochrane Library, and American Psychological Association PsyNet for randomized controlled trials (RCTs) related to placebo-controlled and active intervention trials for PTSD with sleep disorders up to February 2, 2023. RESULTS: Active intervention significantly improved PTSD (standardized mean difference (SMD) = 0.86, 95% confidence interval (CI): 1.21, 0.50), sleep disorders (SMD = 1.06, 95%CI: 1.50, 0.63), and depression (SMD = 0.58, 95%CI: -0.96, -0.19). Regarding compliance, the active intervention group did not show lower acceptability ((Risk ratios (RR) = 1.08, 95%CI: 0.92, 1.26). Compared to placebo or supportive groups, the active intervention did not exhibit statistically significant improvements in total sleep time (SMD = 0.87, 95%CI: -0.27, 1.47) and overall psychological symptoms (SMD = 0.13, 95%CI: -0.12, 0.37). Details results of the subgroup analyses were provided in the text. Bias may be present in total PTSD symptoms, change of total sleep symptoms and change of depression symptoms, and no significant bias was observed in acceptability. CONCLUSION: Active intervention effectively reduces the main symptoms of PTSD in patients with sleep disorders. Consideration of pharmacotherapy (hydroxyzine) is recommended over prazosin, as suggested by the WFSBP clinical guidelines, especially when patients are insensitive to psychotherapy or have urgent symptoms. Psychological interventions, particularly IRT or IRT plus CBT-I, are recommended. Stratified by population, psychotherapy is more advisable for veterans and those with involuntary sexual experiences, while pharmacotherapy is more suitable for military staff. For patients with only nightmare symptoms, both psychotherapy and pharmacotherapy could be considered. When patients have insomnia symptoms, psychotherapy is preferable. The effect of psychotherapy is particularly recommended for females, while the effect of pharmacotherapy is emphasized for males.
背景:创伤后应激障碍(PTSD)与睡眠障碍密切相关,目前PTSD的临床指南在推荐针对伴有睡眠障碍的PTSD患者的治疗方法上存在差异。这项荟萃分析评估了心理治疗、药物治疗以及其他补充/替代疗法的可接受性和疗效,以帮助临床医生为患有PTSD和睡眠障碍的个体制定治疗方案。 方法:我们系统检索了截至2023年2月2日的PubMed、EMBASE、Cochrane图书馆和美国心理学会PsyNet,查找与针对伴有睡眠障碍的PTSD的安慰剂对照和积极干预试验相关的随机对照试验(RCT)。 结果:积极干预显著改善了PTSD(标准化均数差(SMD)=0.86,95%置信区间(CI):1.21,0.50)、睡眠障碍(SMD=1.06,95%CI:1.50,0.
Cochrane Database Syst Rev. 2016-4-4
Cochrane Database Syst Rev. 2018-7-5
Cochrane Database Syst Rev. 2012-12-12
Cochrane Database Syst Rev. 2016-10-11
Cochrane Database Syst Rev. 2017-1-24
Psychopharmacol Bull. 2024-7-8
Klin Spec Psihol. 2022
Sensors (Basel). 2023-3-3
Clin Psychopharmacol Neurosci. 2023-2-28
J Prim Care Community Health. 2023
Int J Environ Res Public Health. 2022-12-31
Can Pharm J (Ott). 2022-4-15